ValuationViz

EW fund manager activity

Edwards Lifesciences Corporation · NYSE. Reported by 16 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalAdded229,603$20,769,8870.03%Aug 14, 2026
Ken Fisher - Fisher Asset ManagementTrimmed87,769$7,939,6300.00%Aug 4, 2026
Jeremy Grantham - GMOAdded20,664$1,869,2650.00%Aug 13, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed100,271$9,070,5150.02%Aug 14, 2026
Torray FundsNo change2,994$270,8370.04%Jul 30, 2026
Viking Global InvestorsSold out——0.00%Aug 14, 2026
David Rolfe - Wedgewood PartnersTrimmed165,208$14,944,7163.08%Aug 14, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalAdded41,176$3,297,3740.01%May 15, 2026
Ken Fisher - Fisher Asset ManagementTrimmed132,199$10,586,5260.00%May 5, 2026
Jeremy Grantham - GMOTrimmed19,050$1,525,5240.00%May 14, 2026
Joel Greenblatt - Gotham Asset ManagementAdded229,827$18,404,5460.06%May 15, 2026
Torray FundsNo change2,994$239,7600.04%May 1, 2026
Viking Global InvestorsNew1,097,578$87,894,0460.25%May 15, 2026
David Rolfe - Wedgewood PartnersTrimmed170,969$13,691,1982.83%May 15, 2026

Older quarters